Telomeres are nucleoprotein structures capping and protecting the ends of chromosomes. Because of the "end replication problem",[@b1] telomeres shorten with each cell division and leucocyte telomere length has been shown to decrease with age at a rate of 20--40 base pairs per year.[@b2] [@b3] Telomere attrition is enhanced by inflammation and oxidative stress and short telomere length is an independent predictor of age related diseases such as hypertension, myocardial infarction, congestive heart failure, vascular dementia, osteoporosis, osteoarthritis and Alzheimer's disease.[@b3]

There is wide inter-individual variability in telomere length at birth and at subsequent ages. Both twin studies and intra-familial correlation analysis have identified a genetic influence (from 40% to 80%) on telomere length variation.[@b4] [@b5] Genome-wide linkage studies have mapped QTLs for this trait to chromosomes 12q12.22[@b5] and 14q23.2.[@b4] More recently Mangino *et al*[@b6] refined the chromosome 12q12.22 locus and described an associated polymorphism (rs2630778) in the *BICD1* gene. To date, none of these findings have been replicated, possibly due to difficulties in measuring this trait in a large number of samples and due to lack of high correlation between the methods used to measure telomere length.

Genome-wide association (GWA) analysis is a powerful tool for unlocking the genetic basis of complex traits and has recently provided novel insights into the genetic architecture of many common diseases and traits.[@b7] [@b8] We therefore undertook a GWA scan to identify common alleles that may influence telomere length. Our findings indicate that single nucleotide polymorphisms (SNPs) rs2162440 and rs7235755 on chromosome 18q12.2 are associated with short telomere length in two independent datasets of European descent.

METHODS {#s2}
=======

We conducted a two stages GWA study on 2790 individuals from the UK Adult Twin Register ([table 1](#JMG-46-07-0451-t01){ref-type="table"}), in which we evaluated 314 075 SNPs. The design and methodology of the GWA study is described in detail elsewhere.[@b7] In brief, the discovery sample consisted of 1625 women from the St Thomas' UK Adult Twin Registry,[@b9] a large cohort of twins historically developed to study the heritability and genetics of diseases with a higher prevalence among women. The sample is not enriched for any particular disease or trait and is representative of the British general population.[@b4] The replication cohort included 1165 subjects of both genders ([table 1](#JMG-46-07-0451-t01){ref-type="table"}) from the UK Twin Registry who were unrelated to the individuals from the discovery sample.

###### Characteristics of the 2790 individuals assessed for telomere length variation

                               Twins UK discovery cohort   Replication cohort   Total sample
  --------------------------- --------------------------- -------------------- --------------
  Subjects assessed for TRF              1625                     1165              2790
  Age (years)\*                       47.9 (12.6)             49.2 (13.6)       48.5 (13.1)
  Males\*                                 --                  48.1 (13.8)       48.1 (13.8)
  Females\*                           47.9 (12.6)             49.5 (13.5)       48.5 (13.0)
  Sex                                     --                      264               264
  Males                                  1625                     901               2526
  Females                                                                      
  LTL\*                               7.02 (0.67)             6.91 (0.68)       6.97 (0.68)
  Males\*                                 --                  6.68 (0.69)       6.68 (0.69)
  Females\*                           7.02 (0.67)             6.98 (0.66)       7.01 (0.67)

LTL, leucocyte telomere length.

\*Values presented as mean (SD).

Leucocyte telomere length (LTL) was derived by using Southern blot analysis in duplicate to measure the mean terminal restriction fragment.[@b10] The coefficient of variation for this measurement was 1.5%. Because all the individuals of the discovery cohort were females, telomere length was only adjusted for age. After adjustment, the trait was normally distributed in the sample.

Genomic DNA was subjected to SNP genotyping via the Infinium assay (Illumina, San Diego, California, USA), using three fully compatible BeadChip microarrays (HumanHap300-Duo, HumanHap300 and HumanHap550), according to the manufacturer's protocols.

We excluded 733 SNPs that had a low call rate (⩽90%), 2704 SNPs that had Hardy--Weinberg p values \<10^−4^, and 725 SNPs with minor allele frequencies \<1%. We also removed subjects where genotyping failed for \>2% of SNPs. We retained for the analysis 98.7% (314 075) of all available SNPs. Statistical analysis was carried out with MERLIN (version 1.1.2)[@b11] using the score test (---fastAssoc), while accounting for family structure and twin zygosity.[@b12]

RESULTS {#s3}
=======

In the discovery sample (n = 1625) the strongest association was recorded for rs7374458 on chromosome 3 (5.20×10^−6^). We also identified 28 SNPs with a p value of ⩽10^−4^ and 316 SNPs with a p value of ⩽10^−3^. We visually inspected all the signal intensity plots of these SNPs and excluded the markers that had been miscalled (11.3%).

Since none observed p values reached a genome-wide significance level after correcting for multiple testing, we adopted the conservative approach of selecting for replication only those polymorphisms with a p value \<10^−3^ that were ≈100 Kb from other associated SNPs (p⩽1.0×10^−2^). Following these criteria, we identified 15 associated loci including a total of 41 SNPs with the p values for the lead SNPs ranging from 5.20×10^−6^ to 9.7×10^−4^ ([table 2](#JMG-46-07-0451-t02){ref-type="table"}).

###### Summary of the 15 loci analysed in discovery and replication cohorts

  Chromosome           Marker       Position    Allele     β GWA (SE)       p Values GWA     β replication (SE)   p Values replication   β combined (SE)   p Values combined     Locus
  ---------------- --------------- ----------- -------- ---------------- ------------------ -------------------- ---------------------- ----------------- ------------------- ------------
  1p35.2              rs7514514     31180643      G      −0.109 (0.025)       1.30E−05         0.035 (0.030)            3.30E−01         −0.049 (0.019)        1.45E−02          PUM1\*
  1p35.2             rs12406355     31190045      A      0.089 (0.024)        1.60E−04           0 (0.027)              1.00E+00          0.05 (0.018)         6.30E−03          PUM1\*
  1q42.13             rs238102      227549771     C       0.08 (0.025)        9.73E−05         0.027 (0.030)            3.80E−01          0.059 (0.019)        2.10E−03         C1orf96§
  1q42.13             rs238099      227575528     A      0.068 (0.023)        2.58E−04         0.006 (0.030)            8.60E−01          0.045 (0.018)        1.70E−02         C1orf96§
  1q42.13             rs7549589     227586550     A      0.062 (0.024)        1.38E−03         −0.002 (0.034)           9.70E−01          0.037 (0.018)        5.70E−02         C1orf96§
  1q44                rs3102458     242606491     A      0.086 (0.028)        2.10E−03         −0.002 (0.033)           1.00E+00          0.045 (0.022)        2.40E−02        C1orf100\*
  1q44                rs3123710     242611441     A      −0.076 (0.023)       1.01E−03         0.015 (0.028)            4.20E−01         −0.041 (0.018)        3.30E−02        C1orf100\*
  1q44                rs3003211     242679607     A      −0.082 (0.025)       8.40E−04         0.018 (0.030)            4.70E−01         −0.042 (0.019)        3.30E−02          ADSS\*
  2q22.2              rs1376749     143683862     G      −0.123 (0.032)       1.10E−04         −0.059 (0.040)           1.49E−01         −0.102 (0.025)        6.20E−05        ARHGAP15\*
  2q22.2             rs12993643     143749432     G      −0.093 (0.025)       1.80E−04         −0.013 (0.030)           6.60E−01         −0.062 (0.019)        1.32E−03        ARHGAP15\*
  2q22.2              rs4662198     143764197     C      −0.095 (0.028)       6.00E−04         −0.025 (0.035)           4.70E−01         −0.069 (0.022)        1.50E−03        ARHGAP15\*
  2q33.1              rs1036533     201105969     G      −0.157 (0.044)       3.90E−04         −0.048 (0.058)           6.10E−01         −0.115 (0.035)        8.90E−04          SGOL2†
  2q33.1             rs10497853     201183402     A      −0.16 (0.045)        4.30E−04         −0.066 (0.057)           2.50E−01         −0.125 (0.036)        1.03E−03          AOX1\*
  3p22--p21.3         rs1858740     38413376      G      −0.081 (0.023)       3.40E−04         0.009 (0.028)            8.30E−01         −0.045 (0.018)        1.34E−02          XYLB\*
  3p22--p21.3         rs4407366     38496429      A      −0.103 (0.023)       8.80E−06          0.04 (0.033)            2.60E−01         −0.054 (0.019)        6.50E−03         ACVR2B\*
  3p22--p21.3         rs7374458     38506215      C      −0.105 (0.023)       5.20E−06          0.02 (0.028)            4.80E−01         −0.054 (0.018)        4.00E−03         ACVR2B‡
  3p14.3              rs3774601     53797933      G       −0.1 (0.024)        3.10E−05         0.049 (0.028)            8.60E−02         −0.038 (0.019)        3.80E−02        CACNA1D\*
  3p14.3              rs3774605     53805807      G       −0.1 (0.024)        3.70E−05         0.053 (0.028)            6.00E−02         −0.035 (0.018)        5.70E−02        CACNA1D\*
  3p14.3              rs3774609     53807943      A      −0.092 (0.024)       1.20E−04          0.04 (0.028)            1.48E−01         −0.036 (0.023)        7.40E−02        CACNA1D\*
  4q31.21             rs1907107     143449084     A      0.073 (0.023)        3.40E−04         −0.009 (0.026)           7.40E−01          0.034 (0.018)        4.90E−02         INPP4B\*
  4q31.21             rs2635429     143463006     G      0.067 (0.023)        2.72E−04         −0.02 (0.027)            4.80E−01          0.029 (0.018)        1.01E−01         INPP4B\*
  4q31.21             rs1497393     143493161     G      −0.066 (0.023)       1.48E−04         0.025 (0.028)            3.70E−01         −0.029 (0.018)        1.10E−01         INPP4B\*
  8p23.1              rs4841067      8784655      A      0.139 (0.032)        1.90E−05          0.01 (0.038)            8.30E−01          0.088 (0.025)        5.70E−04         MFHAS1\*
  8p23.1             rs11778913      8852300      A      0.069 (0.026)        8.10E−03         0.057 (0.033)            8.40E−02          0.067 (0.021)        1.48E−03          THEX1§
  8p23.1             rs11249943      9645273      A      −0.084 (0.029)       3.60E−03         0.021 (0.033)            5.20E−01         −0.037 (0.022)        7.80E−02          TNKS\*
  8p23.1              rs6989782      9647948      G      −0.076 (0.025)       2.52E−04         −0.003 (0.030)           8.80E−01         −0.048 (0.019)        1.14E−02          TNKS\*
  9q31.2              rs1570504     110094630     C      −0.107 (0.033)       1.24E−03         0.016 (0.031)            4.60E−01         −0.055 (0.026)        2.90E−02         ACTL7B‡
  9q31.2              rs1535619     110094886     A      −0.075 (0.031)       1.50E−02         0.004 (0.037)            9.10E−01          −0.04 (0.024)        8.30E−02         ACTL7B‡
  9q31.2              rs7028041     110096538     G      −0.109 (0.034)       1.23E−03         0.017 (0.023)            5.50E−01          −0.05 (0.026)        4.40E−02         ACTL7B‡
  13q31.3             rs9301921     93432990      A       0.08 (0.031)        5.25E−04         0.059 (0.037)            1.06E−01          0.074 (0.024)        2.20E−03          GPC6\*
  13q31.3             rs1415736     93444937      G      0.081 (0.031)        3.70E−04         0.061 (0.043)            1.60E−01          0.075 (0.026)        3.50E−03          GPC6\*
  14q22.2             rs4898848     54266336      A      0.072 (0.024)        4.53E−04         −0.001 (0.028)           8.00E−01          0.04 (0.018)         2.90E−02         SAMD4\*
  14q22.2             rs6572971     54280838      G       0.1 (0.032)         7.90E−04         −0.021 (0.039)           6.00E−01          0.052 (0.025)        4.80E−02         SAMD4\*
  14q22.2             rs1957356     54288744      G      0.092 (0.029)        9.65E−05          0.03 (0.033)            3.90E−01          0.064 (0.022)        2.70E−03         SAMD4\*
  16q24.2--q24.3     rs17214677     82008463      A      0.111 (0.037)        2.80E−03         −0.074 (0.046)           1.12E−01          0.038 (0.029)        2.10E−01         CDH13\*
  16q24.2--q24.3     rs11861722     82125547      A      0.124 (0.038)        9.70E−04         −0.098 (0.043)           2.30E−02          0.021 (0.029)        4.20E−01         CDH13\*
  16q24.2--q24.3      rs9934005     82137699      G      0.088 (0.027)        9.20E−04         −0.028 (0.031)           3.80E−01          0.034 (0.020)        8.50E−02         CDH13\*
  16q24.2--q24.3     rs12598842     82145455      A      −0.059 (0.023)       8.80E−03         −0.007 (0.023)           1.00E+00         −0.038 (0.018)        4.40E−02         CDH13\*
  18q12.2           **rs2162440**   33468004      G      −0.104 (0.029)   **2.50E**−**04**     −0.119 (0.035)       **1.08E**−**03**     −0.106 (0.022)    **2.60E**−**06**     BRUNOL4§
  18q12.2           **rs7235755**   33470259      G      −0.104 (0.028)   **2.60E**−**04**     −0.114 (0.035)       **2.00E**−**03**     −0.103 (0.022)    **5.50E**−**06**     BRUNOL4§
  18q12.2             rs2217127     33475628      C      −0.08 (0.025)        1.30E−03         −0.047 (0.035)           2.20E−01         −0.063 (0.020)        2.10E−03         BRUNOL4§

GWA, genome wide association; SE, standard error.

\*Intron; †coding; ‡flanking 3′ UTR; §flanking 5′UTR.

Values in bold represent the two associated variants.

These 41 selected SNPs were genotyped in the replication cohort (n = 1165) using Sequenom iPLEX (San Diego, California, USA) technology. Because the replication cohort included both males and females, LTL values were adjusted for both gender and age. After adjustment the trait was again normally distributed. To control for multiple testing, we used an SNP spectral decomposition method proposed by Nyholt[@b13] and modified by Li and Ji.[@b14] After spectral decomposition of the linkage disequilibrium (LD) matrices of the 41 analysed SNPs, the corrected threshold of statistical significance in the replication stage was estimated at p⩽2.1×10^−3^ which is a conservative correction for the number of independent SNPs tested in the replication sample. The results of the association analysis are reported in [table 2](#JMG-46-07-0451-t02){ref-type="table"} and show that we were able to replicate the association observed in the GWA sample for two markers, rs2162440 and rs7235755, both mapping to a 2.2 Kb region of chromosome 18q12.2.

Since the discovery cohort included only females, we also performed a gender specific analysis on the replication population in order to test if the genetic variants may be associated with telomere lengths only for females. The result showed that for both SNPs the direction of the trend was consistent between genders in the replication cohort (rs2162440: −100 (44) base pairs (bp) for females and −140 (70) bp for males; rs7235755 −94 (42) bp for females and −138 (71) bp for males) and between females of the two cohorts (rs2162440: −104 (29) bp for female in discovery and −100 (44) bp for females in replication; rs7235755 −104 (28) bp for female in discovery and −94 (42) bp for females in replication). Although borderline (due to small sample size), p values were statistically significant for both SNPs in both genders in the replication cohort (rs2162440: females p = 0.012, males p = 0.046; rs7235755: females p = 0.02, males p = 0.049).

The joint analysis of genotyped data from the two cohorts yielded combined p values of 2.60×10^−6^ (rs2162440) and 5.50×10^−6^ (rs7235755). Our analysis also indicated that the G alleles of both SNPs were associated with shorter telomeres (−106 (22) bp for rs2162440 and −103 (22) bp for rs7235755), extrapolating to an approximate 5 years of telomere erosion based on estimates of loss with age.

DISCUSSION {#s4}
==========

Although our results are unlikely to be artefacts because the identified SNPs were replicated in two independent cohorts, we do believe that our power for identifying association was reduced by the known limitations of the measurement technique.[@b15] Therefore, we can only detect common variants. Indeed, it is likely that there are more loci with small genetic effect that we did not detect because of the stringent thresholds for statistical significance employed in this study. This would explain why we did not detect loci such as those previously identified on chromosome 12q12.22 and 14q23.2.

According to NCBI build 36, the associated polymorphisms map to a 48 Kb LD block within a gene desert, between the Bruno-like 4 (*BRUNOL4*, NM_020180) and *VPS34* (also known as *PIK3C3*, NM_002647) genes. The identified SNPs (or another variant present in the LD block) might be influencing the expression of either transcript through long range control, as has been demonstrated for other genes.[@b16] This hypothesis is supported by the observation that the associated 48 Kb LD block lies in a highly conserved genomic segment. The two associated variants map ∼70 Kb away from *BRUNOL4* and 4.3 Mb away from *VPS34*. *BRUNOL4* is a member of the CELF/Bruno-like family, which encodes proteins bearing highly conserved RNA recognition motif. RNA binding proteins are important elements that control normal cell functions, regulating events such as RNA processing, mRNA transport, stability and translation. *VPS34* is a component of the phosphoinositide (PI) 3 kinase family which includes proteins that regulate several aspect of the cell physiology.[@b17] Interestingly, *VPS34* yeast orthologue (Vps34) has been directly involved in the pathway which regulates telomere length variation.[@b18]

In conclusion, we provide evidence from two independent cohorts for a new locus on chromosome 18q12.2 associated with short telomere length in humans. These data provide new insights into the likely pathways and mechanisms regulating telomere length in humans.
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